Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Robust protection of competition is particularly important in the field of pharmaceuticals as this may help to improve access to affordable medicines and foster medical innovation. While the Antimonopoly Committee of Ukraine (AMCU) has undertaken certain activities in the pharmaceutical sector aimed at combating price increases, these activities do not cover practices that rely on intellectual property (IP) rights that may have a negative effect on the pharmaceutical market. The aim of this chapter is to explore the current competition law approach to IP-related practices in Ukraine. It will discuss certain exemptions related to IP agreements and will suggest that the current competition law rules may require clarification. Specifically, to ensure that only genuinely procompetitive IP agreements are allowed, it will be suggested that it may be necessary to develop specific guidance on the correct interpretation of the law and its application to IP-related agreements. By way of example, the chapter will discuss anticompetitive IP-related agreements that are unique to the pharmaceutical industry, i.e. 'pay-for-delay' agreements. While such agreements have not been the subject of investigation by the AMCU, they have attracted particular attention in the EU and the US. The chapter will discuss the approaches for assessing such agreements developed in the EU and the US, and will provide some recommendations that, it is believed, will help to create more effective competition law enforcement in the field of pharmaceuticals for the benefit of Ukrainian patients. The discussion in this Chapter, while focusing on Ukraine, may also be useful to other jurisdictions that seek to improve their competition law enforcement in the field of IP to facilitate access to medicines.
Robust protection of competition is particularly important in the field of pharmaceuticals as this may help to improve access to affordable medicines and foster medical innovation. While the Antimonopoly Committee of Ukraine (AMCU) has undertaken certain activities in the pharmaceutical sector aimed at combating price increases, these activities do not cover practices that rely on intellectual property (IP) rights that may have a negative effect on the pharmaceutical market. The aim of this chapter is to explore the current competition law approach to IP-related practices in Ukraine. It will discuss certain exemptions related to IP agreements and will suggest that the current competition law rules may require clarification. Specifically, to ensure that only genuinely procompetitive IP agreements are allowed, it will be suggested that it may be necessary to develop specific guidance on the correct interpretation of the law and its application to IP-related agreements. By way of example, the chapter will discuss anticompetitive IP-related agreements that are unique to the pharmaceutical industry, i.e. 'pay-for-delay' agreements. While such agreements have not been the subject of investigation by the AMCU, they have attracted particular attention in the EU and the US. The chapter will discuss the approaches for assessing such agreements developed in the EU and the US, and will provide some recommendations that, it is believed, will help to create more effective competition law enforcement in the field of pharmaceuticals for the benefit of Ukrainian patients. The discussion in this Chapter, while focusing on Ukraine, may also be useful to other jurisdictions that seek to improve their competition law enforcement in the field of IP to facilitate access to medicines.
This paper investigates the role of intellectual property in the modern post-industrial economy and its intensive commercialization of the country's competitive advantages in the global economic environment. The main purpose of the research is to prove the hypothesis about the crucial role of intellectual property development in ensuring expanded public reproduction and facilitating the global competitiveness of national economies through innovative modernization of production. To gain the research aim, the authors used a combination of theoretical synthesis and comprehensive statistical analysis. The study follows a deductive approach and theoretical background analysis followed by quantitative research of statistical data. It allowed arriving essential conclusions concerning the role of intellectual property in strengthening the global competitiveness of the national economy and practical policy implications regarding stimulating intellectual property commercialization within the national economy. Paper investigates transmission mechanisms that represent the impact of intensive commercialization of intellectual property on public reproduction and competitiveness of the national economy. Commercialization of intellectual property, defined as a range of activities envisaged for rapid implementation of intellectual activity, resulted in economic turnover to obtain strategic competitive advantages and generate economic profit supported by the transformation of intellectual property into intellectual capital used for the manufacturing of innovative, highly marginal products. Comprehensive statistical data analysis was conducted using quantitative methods (cluster analysis and principal components analysis). The findings proved the key role of intellectual property in the modern system of public reproduction. They demonstrated the multiplicative impact of intellectual property development on a country's competitive global economic environment. Obtained research results provided the basis for policy implications concerning the development of commercialization of intellectual property and stimulation of expanded reproduction of intellectual capital in Ukraine as a precondition of innovative modernization of national industries and acquiring strategic competitive advantages in a globalized market.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.